{"id":39099,"date":"2026-05-19T13:03:12","date_gmt":"2026-05-19T16:03:12","guid":{"rendered":"https:\/\/crusoe.audiencelabs.com.br\/?p=39099"},"modified":"2026-05-19T08:53:33","modified_gmt":"2026-05-19T11:53:33","slug":"novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa","status":"publish","type":"post","link":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/","title":{"rendered":"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa"},"content":{"rendered":"<div class=\"qMYqUG_convSearchResultHighlightRoot\">\n<div class=\"\" data-turn-id-container=\"request-69fddd60-4f70-83e9-b3e3-dd148e8a040e-4\" data-is-intersecting=\"true\">\n<div class=\"relative w-full overflow-visible\">\n<section class=\"text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-69fddd60-4f70-83e9-b3e3-dd148e8a040e-4\" data-turn-id-container=\"request-69fddd60-4f70-83e9-b3e3-dd148e8a040e-4\" data-testid=\"conversation-turn-134\" data-scroll-anchor=\"false\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"f2450206-ef00-4985-a1ff-b30c62f16e35\" data-message-model-slug=\"gpt-5-5-thinking\" data-turn-start-message=\"true\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\">\n<p data-start=\"253\" data-end=\"893\">A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, em 13 de maio de 2026, uma nova indica\u00e7\u00e3o para o medicamento Datroway no Brasil.<\/p>\n<p data-start=\"253\" data-end=\"893\">A autoriza\u00e7\u00e3o vale para pacientes adultos com c\u00e2ncer de mama triplo-negativo irressec\u00e1vel ou metast\u00e1tico.<\/p>\n<p data-start=\"253\" data-end=\"893\">Ou seja, a medida atende casos em que o tumor n\u00e3o pode ser retirado totalmente por cirurgia ou j\u00e1 se espalhou para outras partes do corpo. Al\u00e9m disso, a indica\u00e7\u00e3o contempla pacientes que n\u00e3o podem receber terapia com inibidores PD-1 ou PD-L1.<\/p>\n<h3 data-section-id=\"uop352\" data-start=\"895\" data-end=\"923\">Tipo agressivo da doen\u00e7a<\/h3>\n<p data-start=\"925\" data-end=\"1158\">O c\u00e2ncer de mama triplo-negativo exige aten\u00e7\u00e3o porque n\u00e3o apresenta tr\u00eas marcadores comuns: receptores de estrog\u00eanio, progesterona e HER2. Esses marcadores orientam tratamentos hormonais ou terapias-alvo em outros subtipos da doen\u00e7a.<\/p>\n<p data-start=\"1160\" data-end=\"1381\">Por isso, esse tipo de c\u00e2ncer costuma ter menos alternativas terap\u00eauticas. A Anvisa classifica o c\u00e2ncer de mama triplo-negativo como uma condi\u00e7\u00e3o agressiva, com r\u00e1pida progress\u00e3o, maior risco de recorr\u00eancia e mortalidade.<\/p>\n<h3 data-section-id=\"143m17p\" data-start=\"1383\" data-end=\"1413\">O que muda com a aprova\u00e7\u00e3o<\/h3>\n<p data-start=\"1415\" data-end=\"1639\">Com a decis\u00e3o, o Datroway passa a integrar o conjunto de medicamentos autorizados para esse grupo espec\u00edfico de pacientes. No entanto, a aprova\u00e7\u00e3o n\u00e3o transforma o rem\u00e9dio em tratamento para todos os casos de c\u00e2ncer de mama.<\/p>\n<p data-start=\"1641\" data-end=\"1822\">A escolha depende da avalia\u00e7\u00e3o do oncologista. Al\u00e9m disso, o m\u00e9dico deve considerar est\u00e1gio da doen\u00e7a, hist\u00f3rico de tratamento, exames, condi\u00e7\u00e3o cl\u00ednica e perfil molecular do tumor.<\/p>\n<p data-start=\"1824\" data-end=\"2161\">Tamb\u00e9m \u00e9 importante diferenciar aprova\u00e7\u00e3o regulat\u00f3ria de acesso imediato. A autoriza\u00e7\u00e3o da Anvisa permite o uso do medicamento no pa\u00eds dentro da indica\u00e7\u00e3o aprovada.<\/p>\n<p data-start=\"1824\" data-end=\"2161\">Por\u00e9m, disponibilidade em hospitais, planos de sa\u00fade ou no Sistema \u00danico de Sa\u00fade (SUS) pode depender de outras etapas, como incorpora\u00e7\u00e3o, negocia\u00e7\u00e3o e protocolos cl\u00ednicos.<\/p>\n<h3 data-section-id=\"a3xqmm\" data-start=\"2163\" data-end=\"2188\">Resolu\u00e7\u00e3o saiu no DOU<\/h3>\n<p data-start=\"2190\" data-end=\"2473\">A Anvisa informou que as novas indica\u00e7\u00f5es terap\u00eauticas sa\u00edram no Di\u00e1rio Oficial da Uni\u00e3o (DOU). Na mesma divulga\u00e7\u00e3o, a ag\u00eancia tamb\u00e9m aprovou nova indica\u00e7\u00e3o para o Imfinzi, usado com Bacillus Calmette-Gu\u00e9rin (BCG) no tratamento de c\u00e2ncer de bexiga n\u00e3o m\u00fasculo-invasivo de alto risco.<\/p>\n<p data-start=\"2475\" data-end=\"2673\" data-is-last-node=\"\" data-is-only-node=\"\">Para pacientes, a orienta\u00e7\u00e3o \u00e9 conversar com a equipe m\u00e9dica e nunca trocar ou interromper tratamento sem acompanhamento especializado.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"z-0 flex min-h-[46px] justify-start\"><\/div>\n<div class=\"mt-3 w-full empty:hidden\">\n<div class=\"text-center\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<div class=\"contents\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"pointer-events-none -mt-px h-px translate-y-[calc(var(--scroll-root-safe-area-inset-bottom)-14*var(--spacing))]\" aria-hidden=\"true\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, em 13 de maio de 2026, uma nova indica\u00e7\u00e3o para o medicamento Datroway no Brasil. A autoriza\u00e7\u00e3o vale para pacientes adultos com c\u00e2ncer de mama triplo-negativo irressec\u00e1vel ou metast\u00e1tico. Ou seja, a medida atende casos em que o tumor n\u00e3o pode ser retirado totalmente por cirurgia ou [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":39100,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard","jnews_video_option_group":[[]],"override":[{"template":"2","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"hide","share_float_style":"share-monocrhome","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0","subtitle":"Medicamento passa a atender pacientes com c\u00e2ncer de mama triplo-negativo avan\u00e7ado"},"jnews_primary_category":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"jnews_post_split":{"post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-39099","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-geral"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, em 13 de maio de 2026, uma nova indica\u00e7\u00e3o para o medicamento Datroway no Brasil. A autoriza\u00e7\u00e3o vale para pacientes adultos com c\u00e2ncer de mama triplo-negativo irressec\u00e1vel ou metast\u00e1tico. Ou seja, a medida atende casos em que o tumor n\u00e3o pode ser retirado totalmente por cirurgia ou [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/\" \/>\n<meta property=\"og:site_name\" content=\"Variedades - Cruso\u00e9\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T16:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sofia Volpi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sofia Volpi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/\",\"url\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/\",\"name\":\"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa\",\"isPartOf\":{\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp\",\"datePublished\":\"2026-05-19T16:03:12+00:00\",\"author\":{\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/9d0fb7a15db57f24b87bef41d034cb04\"},\"breadcrumb\":{\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage\",\"url\":\"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp\",\"contentUrl\":\"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp\",\"width\":1170,\"height\":700,\"caption\":\"Foto: Marcelo Camargo\/Ag\u00eancia Brasil\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/crusoe.audiencelabs.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/#website\",\"url\":\"https:\/\/crusoe.audiencelabs.com.br\/\",\"name\":\"Variedades - Cruso\u00e9\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/crusoe.audiencelabs.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/9d0fb7a15db57f24b87bef41d034cb04\",\"name\":\"Sofia Volpi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a34b676379e5491536434fe5f7a9c49c2efbf9be83b707fa9e74568d45d559f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a34b676379e5491536434fe5f7a9c49c2efbf9be83b707fa9e74568d45d559f8?s=96&d=mm&r=g\",\"caption\":\"Sofia Volpi\"},\"description\":\"Comunicadora, jornalista em forma\u00e7\u00e3o. Apaixonada por esportes e cultura, colunista.\",\"url\":\"https:\/\/crusoe.audiencelabs.com.br\/author\/sofiavolpi\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/","og_locale":"pt_BR","og_type":"article","og_title":"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, em 13 de maio de 2026, uma nova indica\u00e7\u00e3o para o medicamento Datroway no Brasil. A autoriza\u00e7\u00e3o vale para pacientes adultos com c\u00e2ncer de mama triplo-negativo irressec\u00e1vel ou metast\u00e1tico. Ou seja, a medida atende casos em que o tumor n\u00e3o pode ser retirado totalmente por cirurgia ou [&hellip;]","og_url":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/","og_site_name":"Variedades - Cruso\u00e9","article_published_time":"2026-05-19T16:03:12+00:00","og_image":[{"width":1170,"height":700,"url":"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp","type":"image\/webp"}],"author":"Sofia Volpi","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Sofia Volpi","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/","url":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/","name":"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa","isPartOf":{"@id":"https:\/\/crusoe.audiencelabs.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage"},"image":{"@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp","datePublished":"2026-05-19T16:03:12+00:00","author":{"@id":"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/9d0fb7a15db57f24b87bef41d034cb04"},"breadcrumb":{"@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#primaryimage","url":"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp","contentUrl":"https:\/\/cdn.crusoe.com.br\/uploads\/2026\/05\/anvisa-ebc.webp","width":1170,"height":700,"caption":"Foto: Marcelo Camargo\/Ag\u00eancia Brasil"},{"@type":"BreadcrumbList","@id":"https:\/\/crusoe.audiencelabs.com.br\/novo-tratamento-contra-o-cancer-de-mama-e-aprovado-pela-anvisa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/crusoe.audiencelabs.com.br\/"},{"@type":"ListItem","position":2,"name":"Novo tratamento contra o c\u00e2ncer de mama \u00e9 aprovado pela Anvisa"}]},{"@type":"WebSite","@id":"https:\/\/crusoe.audiencelabs.com.br\/#website","url":"https:\/\/crusoe.audiencelabs.com.br\/","name":"Variedades - Cruso\u00e9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crusoe.audiencelabs.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/9d0fb7a15db57f24b87bef41d034cb04","name":"Sofia Volpi","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/crusoe.audiencelabs.com.br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a34b676379e5491536434fe5f7a9c49c2efbf9be83b707fa9e74568d45d559f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a34b676379e5491536434fe5f7a9c49c2efbf9be83b707fa9e74568d45d559f8?s=96&d=mm&r=g","caption":"Sofia Volpi"},"description":"Comunicadora, jornalista em forma\u00e7\u00e3o. Apaixonada por esportes e cultura, colunista.","url":"https:\/\/crusoe.audiencelabs.com.br\/author\/sofiavolpi\/"}]}},"_links":{"self":[{"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/posts\/39099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/comments?post=39099"}],"version-history":[{"count":1,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/posts\/39099\/revisions"}],"predecessor-version":[{"id":39101,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/posts\/39099\/revisions\/39101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/media\/39100"}],"wp:attachment":[{"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/media?parent=39099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/categories?post=39099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crusoe.audiencelabs.com.br\/wp-json\/wp\/v2\/tags?post=39099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}